Stockscreener 앱 받기
33.40
1.85%
-0.63
시간 외 거래:
33.40
전일 마감가:
$34.03
열려 있는:
$33.67
하루 거래량:
716.67K
Relative Volume:
1.09
시가총액:
$1.52B
수익:
$1.18B
순이익/손실:
$2.05M
주가수익비율:
773.15
EPS:
0.0432
순현금흐름:
$66.94M
1주 성능:
-4.84%
1개월 성능:
-13.54%
6개월 성능:
+6.57%
1년 성능:
-3.75%
1일 변동 폭
$33.27
$34.24
1주일 범위
$33.27
$35.62
52주 변동 폭
$22.66
$55.00
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
33.40 | 1.55B | 1.18B | 2.05M | 66.94M | 0.0432 |
|
VEEV
Veeva Systems Inc
|
185.59 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.74 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.99 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.13 | 6.80B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
MMED
Minimed Group Inc
|
17.11 | 4.71B | 0 | 0 | 0 | 0.00 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Medication Therapy Management Market Current Impact to Make Big Changes | CVS Health, Walgreens, Omnicell - openPR.com
Omnicell, Inc. (OMCL): A bull case theory - MSN
Omnicell (NASDAQ:OMCL) EVP Corey Manley Sells 7,405 Shares - MarketBeat
Omnicell (NASDAQ: OMCL) CEO RSUs vest; shares withheld for taxes - Stock Titan
Omnicell (OMCL) COO gains 37,409 shares; 8,456 withheld for taxes - Stock Titan
Omnicell (OMCL) EVP Manley reports PSU vesting, tax withholding and share sale - Stock Titan
Q4 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
OMCL (NASDAQ: OMCL) affiliate sales; 7,405 restricted shares vest on 03/15/2026 - Stock Titan
Benchmark reiterates Omnicell stock rating on product cycle outlook - Investing.com Australia
Benchmark reiterates Omnicell stock rating on product cycle outlook By Investing.com - Investing.com UK
Pier Capital LLC Reduces Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (NASDAQ:OMCL) Rating Increased to Hold at Zacks Research - MarketBeat
Telepharmacy Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Omnicell (OMCL) to Participate in Benchmark's Virtual Meeting on March 11 - GuruFocus
How Omnicell Inc. (OMCL) Affects Rotational Strategy Timing - Stock Traders Daily
Dynamic Technology Lab Private Ltd Acquires 24,738 Shares of Omnicell, Inc. $OMCL - MarketBeat
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Quantbot Technologies LP Purchases Shares of 25,813 Omnicell, Inc. $OMCL - MarketBeat
Pharmacy Repackaging Systems Market Is Going to Boom Rapidly | - openPR.com
Intech Investment Management LLC Sells 135,679 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story - Sahm
Aug Patterns: Is Omnicell Inc a play on infrastructure spendingGold Moves & High Conviction Investment Ideas - baoquankhu1.vn
How The Titan XT Cycle Is Rewriting The Omnicell (OMCL) Investment Story - Yahoo Finance
Will Strong Q4 Beat and Software Pivot Change Omnicell's (OMCL) Investment Narrative? - Yahoo Finance
JPMorgan Chase & Co. Sells Omnicell, Inc. $OMCL Shares - National Today
Omnicell, Inc. $OMCL Shares Sold by JPMorgan Chase & Co. - MarketBeat
Omnicell Stock Analysis: Strong Performance vs. Long-Term ConcernsNews and Statistics - IndexBox
OMCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings And Nearly 40% Upside Potential - DirectorsTalk Interviews
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Yahoo Finance
Vanguard Group Inc. Has $170.89 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Roubaix Capital LLC Purchases Shares of 76,383 Omnicell, Inc. $OMCL - MarketBeat
Assessing Omnicell (OMCL) Valuation As ANiGENT Deal Accelerates Shift To Software And Services - simplywall.st
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Dividend Watch: Whats the fair value of Omnicell Inc stockEarnings Overview Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors? - simplywall.st
Omnicell, Inc. (OMCL): A Bull Case Theory - Finviz
OMCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is Zacks Research's Estimate for Omnicell Q3 Earnings? - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus
(OMCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on May 22, 2025. - marketscreener.com
Omnicell, Inc. (OMCL) Investor Outlook: Examining a 45% Potential Upside Amid Healthcare Innovation - DirectorsTalk Interviews
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Finviz
Healthcare Inventory Management Market Hits New High | Major - openPR.com
Omnicell Inc (OMCL) Trading 3.26% Higher on Feb 20 - GuruFocus
Omnicell (OMCL) COO has 1,146 shares withheld for RSU taxes - Stock Titan
Omnicell (OMCL) insider plans Rule 144 sale of 4,243 vested shares - Stock Titan
Hospital Robotics (Logistics and Pharmacy) Market to Reach USD - openPR.com
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.94%
자본화:
|
볼륨(24시간):